Bumetanide for Core Symptoms of Autism Spectrum Disorder (BAMBI): a Single Center, Double-Blinded, Participant-Randomized, Placebo-Controlled, Phase 2, Superiority Trial

Jan Sprengers, Dorinde M. Van Andel, Nicolaas P.A. Zuithoff, Mandy G. Keijzer-Veen, Annelien J. A. Schulp, F. E. Scheepers, Marc R. Lilien, Bob Oranje, H Bruining

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Publication statusAccepted/In press - 2020

Cite this